2011 annual financial data

XTL Biopharmaceuticals 2011 Financial results

XTL Biopharmaceuticals 2011 financial results with verified reported values.

Direct answer

Revenue was Not available.

Operating income was -1,163,000 USD and net income was -1,207,000 USD.
Operating cash flow was -1,801,000 USD.

Get free XTL Biopharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
Not available
Operating income
-1,163,000 USD
Net income
-1,207,000 USD
Operating cash flow
-1,801,000 USD